Alain Gendron

1.9k total citations · 1 hit paper
34 papers, 1.5k citations indexed

About

Alain Gendron is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alain Gendron has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alain Gendron's work include Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (7 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Alain Gendron is often cited by papers focused on Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (7 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers). Alain Gendron collaborates with scholars based in Canada, United Kingdom and United States. Alain Gendron's co-authors include Émmanuel Stip, Édouard Kouassi, Stéphane Potvin, Amir A. Sepehry, Amanda McIntyre, Olivier Lipp, Roch-Hugo Bouchard, R Élie, Marc‐André Roy and Marie‐France Demers and has published in prestigious journals such as Stroke, Biological Psychiatry and Brain Research.

In The Last Decade

Alain Gendron

33 papers receiving 1.4k citations

Hit Papers

Inflammatory Cytokine Alterations in Schizophrenia: A Sys... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
    2007 807 citations Stéphane Potvin, Émmanuel Stip et al. Biological Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Gendron Canada 17 725 610 357 296 277 34 1.5k
Mandana Ashrafi Iran 22 866 1.2× 761 1.2× 369 1.0× 270 0.9× 152 0.5× 31 2.2k
Nico J.M. van Beveren Netherlands 22 657 0.9× 495 0.8× 242 0.7× 122 0.4× 162 0.6× 41 1.4k
Sinead M. Gibney Ireland 15 896 1.2× 242 0.4× 577 1.6× 185 0.6× 336 1.2× 22 1.6k
Elaine Setiawan Canada 15 727 1.0× 134 0.2× 521 1.5× 115 0.4× 444 1.6× 16 1.3k
Vanessa Ota Brazil 22 551 0.8× 452 0.7× 292 0.8× 56 0.2× 139 0.5× 81 1.4k
Gerald Vogt United States 6 927 1.3× 211 0.3× 720 2.0× 86 0.3× 231 0.8× 7 1.2k
C. Vandervorst Belgium 13 816 1.1× 242 0.4× 696 1.9× 132 0.4× 133 0.5× 15 1.2k
Daniel M. Pearlman United States 13 551 0.8× 231 0.4× 233 0.7× 53 0.2× 335 1.2× 16 1.3k

Countries citing papers authored by Alain Gendron

Since Specialization
Citations

This map shows the geographic impact of Alain Gendron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Gendron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Gendron more than expected).

Fields of papers citing papers by Alain Gendron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Gendron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Gendron. The network helps show where Alain Gendron may publish in the future.

Co-authorship network of co-authors of Alain Gendron

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Gendron. A scholar is included among the top collaborators of Alain Gendron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Gendron. Alain Gendron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Migneault, Francis, Alain Gendron, Isabelle Bourdeau, et al.. (2025). Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injury. JCI Insight. 10(10).
2.
Noorduyn, Stephen G., et al.. (2021). Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma. ERJ Open Research. 7(4). 465–2021. 3 indexed citations
3.
Lee, Jason K., et al.. (2021). Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study. ERJ Open Research. 7(1). 778–2020. 4 indexed citations
4.
Lee, Jason K., et al.. (2020). <p>Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada</p>. Patient Preference and Adherence. Volume 14. 725–735. 9 indexed citations
5.
Husereau, Don, et al.. (2018). Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data. Allergy Asthma and Clinical Immunology. 14(1). 15–15. 19 indexed citations
6.
7.
Chue, Pierre, Ashok Malla, Roch-Hugo Bouchard, et al.. (2013). The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia. Current Medical Research and Opinion. 29(3). 227–239. 8 indexed citations
8.
Potvin, Stéphane, et al.. (2012). Add-on Treatment of Quetiapine for Fibromyalgia. Journal of Clinical Psychopharmacology. 32(5). 684–687. 26 indexed citations
9.
Honer, William G., G. William MacEwan, Alain Gendron, et al.. (2011). A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. 73(1). 13–20. 18 indexed citations
10.
Zhornitsky, Simon, Émmanuel Stip, Tania Pampoulova, et al.. (2011). Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine. Frontiers in Psychiatry. 2. 22–22. 11 indexed citations
11.
Potvin, Stéphane, Émmanuel Stip, Roch-Hugo Bouchard, et al.. (2011). Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(7). 1695–1698. 26 indexed citations
12.
Rizkallah, Élie, Émmanuel Stip, Simon Zhornitsky, et al.. (2010). Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion on Pharmacotherapy. 11(18). 2947–2951. 5 indexed citations
13.
Katzman, Martin A., et al.. (2008). Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial. Journal of Anxiety Disorders. 22(8). 1480–1486. 40 indexed citations
14.
Mamo, David C., Hiroyuki Uchida, Irina Vitcu, et al.. (2008). Quetiapine Extended-Release Versus Immediate-Release Formulation. The Journal of Clinical Psychiatry. 69(1). 81–86. 36 indexed citations
15.
Yan, Bin, Xiaoying Bi, Jue He, et al.. (2007). Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice. Life Sciences. 81(5). 353–361. 32 indexed citations
16.
Potvin, Stéphane, Émmanuel Stip, Olivier Lipp, et al.. (2007). Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia. The American Journal of Drug and Alcohol Abuse. 34(1). 75–82. 18 indexed citations
17.
Potvin, Stéphane, et al.. (2007). Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review. Biological Psychiatry. 63(8). 801–808. 807 indexed citations breakdown →
18.
Potvin, Stéphane, Émmanuel Stip, Olivier Lipp, et al.. (2006). Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion. 22(7). 1277–1285. 59 indexed citations
19.
20.
Gendron, Alain, Jeanne Teitelbaum, Chantal Cossette, et al.. (2002). Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Research. 955(1-2). 85–97. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mandana Ashrafi Breakdown of academic impact, for papers by Nico J.M. van Beveren Breakdown of academic impact, for papers by Sinead M. Gibney Breakdown of academic impact, for papers by Elaine Setiawan Breakdown of academic impact, for papers by Vanessa Ota Breakdown of academic impact, for papers by Gerald Vogt Breakdown of academic impact, for papers by C. Vandervorst Breakdown of academic impact, for papers by Daniel M. Pearlman
Rankless by CCL
2026